Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-07-18 Sale | 2022-07-18 6:53 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 6,000 | $24.4 | $146,374 | 205,199 (Indirect Direct) | View |
| 2022-07-08 Sale | 2022-07-12 7:30 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 2,197 | $25.41 | $55,835 | 256,649 (Direct) | View |
| 2022-07-08 Sale | 2022-07-12 7:30 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 13,500 | $25.37 | $342,473 | 981,733 (Indirect Direct) | View |
| 2022-07-06 Sale | 2022-07-07 4:04 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 1,000 | $22.07 | $22,070 | 876,298 (Indirect Direct) | View |
| 2022-06-24 Sale | 2022-06-28 4:29 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner | 341,971 | $21.31 | $7,287,402 | 415,142 (Indirect) | View |
| 2022-06-06 Sale | 2022-06-06 4:06 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 1,000 | $21.06 | $21,064 | 877,298 (Indirect Direct) | View |
| 2022-05-27 Sale | 2022-06-02 4:48 pm | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru VP | 1,795 | $19.73 | $35,419 | 16,380 (Direct) | View |
| 2022-06-01 Sale | 2022-06-02 4:48 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,500 | $20.62 | $51,539 | 248,365 (Indirect Direct) | View |
| 2022-05-05 Sale | 2022-05-05 5:31 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 1,000 | $21.76 | $21,760 | 876,681 (Indirect Direct) | View |
| 2022-05-02 Sale | 2022-05-03 5:14 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,500 | $20.44 | $51,112 | 256,975 (Indirect Direct) | View |
| 2022-04-21 Sale | 2022-04-21 6:32 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 2,197 | $20.42 | $44,872 | 257,229 (Direct) | View |
| 2022-04-06 Sale | 2022-04-08 6:06 pm | Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner | 878,200 | $20.68 | $18,163,608 | 451,086 (Indirect) | View |
| 2022-04-05 Sale | 2022-04-05 6:45 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 1,000 | $21.43 | $21,430 | 877,681 (Indirect Direct) | View |
| 2022-04-01 Sale | 2022-04-01 4:55 pm | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 7,500 | $20.02 | $150,184 | 214,493 (Indirect Direct) | View |
| 2022-03-09 Sale | 2022-03-11 9:42 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 300 | $17 | $5,100 | 878,681 (Indirect Direct) | View |
| 2022-03-03 Sale | 2022-03-07 8:59 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 3,259 | $16.9 | $55,088 | 1,186,016 (Indirect Direct) | View |
| 2022-03-03 Sale | 2022-03-07 8:53 pm | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 1,011 | $16.85 | $17,032 | 90,139 (Direct) | View |
| 2022-03-03 Sale | 2022-03-07 8:49 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 1,023 | $16.85 | $17,234 | 79,311 (Direct) | View |
| 2022-03-03 Sale | 2022-03-07 8:49 pm | Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L CFO | 303 | $16.85 | $5,104 | 70,556 (Direct) | View |
| 2022-03-03 Sale | 2022-03-07 8:48 pm | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 1,023 | $16.85 | $17,234 | 66,413 (Direct) | View |
| 2022-03-03 Sale | 2022-03-07 8:47 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 856 | $16.85 | $14,420 | 294,726 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:18 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 2,153 | $17.75 | $38,222 | 810,640 (Indirect Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:18 pm | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 775 | $17.75 | $13,758 | 246,982 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:17 pm | Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L CFO | 420 | $17.75 | $7,456 | 22,259 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:16 pm | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 936 | $17.75 | $16,617 | 18,836 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:15 pm | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 935 | $17.75 | $16,599 | 31,734 (Direct) | View |
| 2022-02-09 Sale | 2022-02-11 5:55 pm | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 1,000 | $17 | $17,000 | 932,428 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-23(A) Exercise | 2022-08-04 8:42 pm | N/A 2029-11-20 | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 15,331 | $0 | 191,056 (Direct) | View |
| 2022-03-23(A) Exercise | 2022-08-04 8:42 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 15,331 | $6.52 | 191,056 (Direct) | View |
| 2022-07-08 Exercise | 2022-07-12 7:30 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 7,087 | $0 | 981,733 (Direct) | View |
| 2022-07-08 Exercise | 2022-07-12 7:30 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 7,087 | $1.6806 | 981,733 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:58 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director | 16,108 | $0 | 16,108 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:57 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director | 16,108 | $0 | 907,480 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:56 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director | 16,108 | $0 | 16,108 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:55 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 16,108 | $0 | 222,995 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:54 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | LIN SUE-JEAN Director | 16,108 | $0 | 16,408 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:53 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | Heron Patrick J Director 10% Owner | 16,108 | $0 | 16,108 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:52 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | Leonard Keith R Director | 16,108 | $0 | 17,858 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:51 pm | N/A 2032-06-01 | Arcutis Biotherapeutics Inc. | ARQT | TURNER JOSEPH L Director | 16,108 | $0 | 16,108 (Direct) | View |
| 2022-05-27 Option Award | 2022-06-02 4:48 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru VP | 4,875 | $0 | 16,380 (Direct) | View |
| 2022-06-01 Exercise | 2022-06-02 4:48 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,500 | $0 | 248,365 (Direct) | View |
| 2022-06-01 Exercise | 2022-06-02 4:48 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,500 | $1.6806 | 248,365 (Direct) | View |
| 2022-05-02 Exercise | 2022-05-03 5:14 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 2,500 | $0 | 256,975 (Direct) | View |
| 2022-05-02 Exercise | 2022-05-03 5:14 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,496 | $0.5802 | 256,975 (Direct) | View |
| 2022-05-02 Exercise | 2022-05-03 5:14 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 1,004 | $1.6806 | 256,975 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-01 4:55 pm | N/A 2028-06-13 | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 7,500 | $0 | 214,493 (Direct) | View |
| 2022-04-01 Exercise | 2022-04-01 4:55 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director | 7,500 | $0.5802 | 214,493 (Direct) | View |
| 2022-03-23(A) Exercise | 2022-03-30 8:02 pm | N/A 2029-11-20 | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 25,328 | $0 | 191,056 (Direct) | View |
| 2022-03-23(A) Exercise | 2022-03-30 8:02 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 25,328 | $6.52 | 191,056 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-25 4:11 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 25,328 | $6.52 | 191,056 (Direct) | View |
| 2022-03-23 Disposition | 2022-03-25 4:11 pm | N/A 2029-11-20 | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 25,328 | $0 | 191,056 (Direct) | View |
| 2022-03-03 Exercise | 2022-03-07 8:59 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 700 | $0 | 1,186,016 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:59 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 259,000 | $0 | 1,186,016 (Direct) | View |
| 2022-03-03 Exercise | 2022-03-07 8:59 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 700 | $1.6806 | 1,186,016 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:53 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks | 64,900 | $0 | 90,139 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:52 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru VP | 48,600 | $0 | 48,600 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:49 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer | 48,600 | $0 | 79,311 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:49 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L CFO | 48,600 | $0 | 70,556 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:48 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. VP | 48,600 | $0 | 66,413 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:47 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W CTO | 48,600 | $0 | 294,726 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:46 pm | N/A 2032-03-03 | Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard SVP and Chief Business Officer | 48,600 | $0 | 48,600 (Direct) | View |
| 2022-02-09 Exercise | 2022-02-11 5:55 pm | N/A 2029-03-13 | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 1,000 | $0 | 932,428 (Direct) | View |
| 2022-02-09 Exercise | 2022-02-11 5:55 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin CEO | 1,000 | $1.6806 | 932,428 (Direct) | View |